Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.92 USD | -1.16% | -5.16% | +31.28% |
06-13 | Halozyme Therapeutics Insider Sold Shares Worth $1,006,300, According to a Recent SEC Filing | MT |
06-11 | Halozyme Therapeutics May Seeks M&A | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.28% | 6.3B | |
+17.47% | 124B | |
+18.79% | 112B | |
+3.52% | 22.94B | |
-11.12% | 17.02B | |
-16.50% | 16.88B | |
-39.57% | 16.87B | |
+2.89% | 13.63B | |
+24.18% | 11.61B | |
+107.45% | 10.31B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Insider Sell: Halozyme Therapeutics